False positive thallium-201 SPECT imaging in brain abscess

British Journal of Radiology

Volumn 73, Issue 866, 2000, Pages 160-164

  Martinez Del Valle M D ^a   Gomez Rio M ^a   Horcajadas, A ^a   Rodriguez Fernandez A ^a   Muros De Fuentes, M A ^a   Acosta Gomez M J ^a   Castaneda M ^a   Llamas Elvira, J M ^a   Arjona, V ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

THALLIUM CHLORIDE TL 201; TRACER;

ADULT; AGED; ARTICLE; BRAIN ABSCESS; BRAIN TUMOR; CASE REPORT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENTEROCOCCUS FAECALIS; HUMAN; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR PROMOTION;

EID: 0343963023     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.866.10884729     Document Type: Article

References (28)

1. Tyler JL, Byrne TN. Neoplastic disorders. In: Mazziota JC, Gilman S, editors. Clinical brain imaging. Philadelphia, PA: F.A. Davis Company, 1992:166-218.
2. 99mTc-HMPAO leukocyte scintigraphy and C-reactive protein levels in the differential diagnosis of brain abscesses. J Neurosurg 1992;77:732-6.
3. Dierckx RA, Martin JJ, Dobbeleir A, Rols R, Neetens I, De Deyn PP. Sensitivity and specificity of thallium-201 SPECT in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994;21:621-33.
4. Schwartz RB. Neuroradiology of brain tumors. In: Wen PY, Black PMcL, editors. Neurologic clinics: brain tumors in adults. Philadelphia, PA: W.B. Saunders Company, 1995:723-56.
5. 99mTc-HMPAO labeled leukocyte SPECT in intracranial lesions. Surg Neurol 1995;44:338-45.
6. Palestro CJ, Swyer AJM, Kim CK, Muzinic M, Goldsmith SJ. Role of In-111 labelled leukocyte scintigraphy in the diagnosis of intracerebral lesions. Clin Nucl Med 1991;16:305-8.
7. Schmidt KG, Rasmussen JW, Frederiksen PB, Kock-Jensen C, Pedersen NT. Indium-111 granulocyte scintigraphy in brain abscess diagnosis: limitations and pitfalls. J Nucl Med 1990;31:1121-7.
8. Gruber ML, Hochberg FH. Systematic evaluation of primary brain tumors (editorial). J Nucl Med 1990;31:969-71.
9. Tonami N, Hisada K. Thallium-201 SPECT in the evaluation of gliomas (editorial). J Nucl Med 1993; 34:2089-90.
10. 201Tl chloride. Clin Nucl Med 1977;2: 75-81.
11. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342-6.
12. Oriuchi N, Tamura M, Shibazaki T, Ohye CH, Watanabe N, Tateno M, et al. Clinical evaluation of thallium-201 SPECT in supratetorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993;34:2085-9.
13. Källén K. Heiling M. Andersson AM, Brun A, Holtás S, Ryding E. Preoperative grading of glioma malignancy with thallium-201 SPECT: comparison with conventional CT. Am J Neuroradiol 1996;17: 925-32.
14. Mountz JM, Deutsch G. Kuzniecky R, Rosenfeld SS. Brain SPECT: 1994 update. In: Freeman LM, editor. Nucl Med Annual 1994. New York, NY: Raven Press, 1994;1-54.
15. Kline JL, Noto RB, Glantz M. Single photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. Am J Neuroradiol 1996;17:1681-6.
16. Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, Da Costa M, et al. The role of thallium-201 and retention in intracranial tumors after radiotherapy. J Nucl Med 1997;38:223-6.
17. Ruiz A, Ganz WI, Post MJ, Camp A, Landy H, Mallin W. et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. Am J Neuroradiol 1994;15:1885-94.
18. Lomeña F, Vidal-Sicart S, Cruceta A, Pavía J, Miró JM, Mañé S, et al. Predictive value of 201-thallium SPECT in the diagnosis of primary brain lymphoma in AIDS patients (abstract). Eur J Nucl Med 1997; 24:859.
19. Gomez Rio M, Martínez del Valle MD, Rodriguez A, Ureña M, Muros MA, Acosta MJ, et al. Radionecrosis vs tumoral recurrence in brain tumours: diagnosis using T1-201 SPECT (abstract). In: 7th World Congress of Nuclear Medicine and Biology and European Association of Nuclear Medicine; Berlin: 1998. Eur J Nucl Med 1998;8:922, OS-344.
20. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47-52.
21. Mountz JM, Raymond PA, McKeever PE, Modell JG, Hood TW, Barthel LK, et al. Specific localization of thallium-201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989; 49;4053-6.
22. 201 Tl in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987;12:567-72.
23. Cox J, Murtagh FR, Wilfong A, Brenner J. Cerebral aspergillosis: MR imaging and histopathologic correlation. Am J Neuroradiol 1992;5: 1489-92.
24. Tonami H, Matsuda H, Ooba H, Yokoyama K, Hisada K, Ikeda K. et al. Thallium-201 accumulation in cerebral candidiasis. Clin Nucl Med 1990;15:397-400.
25. Krishna L, Slizofski WJ, Katsetos CD, Nair S, Dadparvar S, Brown S, et al. Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 1992;33:2017-9.
26. Kim KT, Black KL, Marciano D, Mazziota JC, Guze BH, Grafton S, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965-9.
27. Lorberboym M, Wallach F, Estok L, Mosesson RE, Sacher M, Kim CK, et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med 1998;39: 1366-9.
28. Sato S, Ogasawara K, Kinouchi H, Kohsyu K, Yoshimoto T. Probable brain abscess presenting as a high uptake lesion on thallium-201 single photon emission computed tomography. Case report. Neurol Med Chir 1997;37:775-8.